SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales slipped to Rs. 2784.02 millions for the September 2022 quarter as against Rs. 3009.88 millions during the year-ago period.Profit after Tax for the quarter ended September 2022 saw a decline of -31.49% from Rs. 1151.98 millions to Rs. 789.22  millions.Operating Profit reported a sharp decline to 1170.32 millions from 1601.10 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 2784.02 3009.88 -7.50 6172.01 5647.89 9.28 13202.22 10097.19 30.75
Other Income 103.89 383.35 -72.90 212.87 441.18 -51.75 1877.88 142.37 1219.01
PBIDT 1170.32 1601.10 -26.91 2826.69 2805.09 0.77 7677.76 4547.59 68.83
Interest 2.90 11.75 -75.32 17.23 33.01 -47.80 62.31 91.44 -31.86
PBDT 1167.42 1589.35 -26.55 2809.46 2772.08 1.35 7615.45 4456.15 70.90
Depreciation 107.56 91.77 17.21 213.04 181.70 17.25 390.97 316.36 23.58
PBT 1059.86 1497.58 -29.23 2596.42 2590.38 0.23 7224.48 4139.79 74.51
TAX 270.64 345.60 -21.69 666.69 623.99 6.84 1643.49 1053.32 56.03
Deferred Tax 14.39 17.80 -19.16 21.63 24.56 -11.93 67.19 36.17 85.76
PAT 789.22 1151.98 -31.49 1929.73 1966.39 -1.86 5580.99 3086.47 80.82
Equity 254.57 254.57 0.00 254.57 254.57 0.00 254.57 254.57 0.00
PBIDTM(%) 42.04 53.19 -20.98 45.80 49.67 -7.79 58.16 45.04 29.12

Cohance Lifesciences Share Price

363.30 0.05 (0.01%)
17-Apr-2026 10:17 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1694.80
Dr. Reddys Lab 1223.50
Cipla 1240.05
Zydus Lifesciences 944.60
Lupin 2333.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×